274 related articles for article (PubMed ID: 15654008)
1. Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease.
Al-Salmi QA; Walter JN; Colasurdo GN; Sockrider MM; Smith EO; Takahashi H; Fan LL
Chest; 2005 Jan; 127(1):403-7. PubMed ID: 15654008
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
Ohnishi H; Yokoyama A; Kondo K; Hamada H; Abe M; Nishimura K; Hiwada K; Kohno N
Am J Respir Crit Care Med; 2002 Feb; 165(3):378-81. PubMed ID: 11818324
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
5. KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia.
Daimon T; Tajima S; Oshikawa K; Bando M; Ohno S; Sugiyama Y
Intern Med; 2005 Aug; 44(8):811-7. PubMed ID: 16157978
[TBL] [Abstract][Full Text] [Related]
6. Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis.
Veselý R; Vargová V; Ravelli A; Massa M; Oleksák E; D'Alterio R; Martini A; De Benedetti F
J Rheumatol; 2004 Apr; 31(4):795-800. PubMed ID: 15088311
[TBL] [Abstract][Full Text] [Related]
7. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
Chen F; Shu XM; Wang DX; Xie Y; Wang GC
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
[TBL] [Abstract][Full Text] [Related]
8. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.
Hamada T; Samukawa T; Kumamoto T; Hatanaka K; Tsukuya G; Yamamoto M; Machida K; Watanabe M; Mizuno K; Higashimoto I; Inoue Y; Inoue H
BMC Pulm Med; 2015 Sep; 15():110. PubMed ID: 26424433
[TBL] [Abstract][Full Text] [Related]
9. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
[TBL] [Abstract][Full Text] [Related]
10. [Lung injury and serum markers].
Suwabe A
Rinsho Byori; 2002 Nov; 50(11):1061-6. PubMed ID: 12491603
[TBL] [Abstract][Full Text] [Related]
11. A case of Wilson-Mikity syndrome with high serum KL-6 levels.
Takami T; Kumada A; Takei Y; Miyajima T; Hoshika A
J Perinatol; 2003 Jan; 23(1):56-8. PubMed ID: 12556928
[TBL] [Abstract][Full Text] [Related]
12. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
[TBL] [Abstract][Full Text] [Related]
13. Gefitinib-induced interstitial lung disease showing improvement after cessation: disassociation of serum markers.
Kitajima H; Takahashi H; Harada K; Kanai A; Inomata S; Taniguchi H; Saikai T; Abe S
Respirology; 2006 Mar; 11(2):217-20. PubMed ID: 16548909
[TBL] [Abstract][Full Text] [Related]
14. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia.
Ishii H; Mukae H; Kadota J; Kaida H; Nagata T; Abe K; Matsukura S; Kohno S
Thorax; 2003 Jan; 58(1):52-7. PubMed ID: 12511721
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
[TBL] [Abstract][Full Text] [Related]
16. [Interstitial pneumonitis and serum markers (SP-D & KL-6) in collagen vascular diseases].
Sagawa A
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Apr; 27(2):55-63. PubMed ID: 15164926
[No Abstract] [Full Text] [Related]
17. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.
Kobayashi H; Kanoh S; Motoyoshi K
Biomarkers; 2008 Jun; 13(4):385-92. PubMed ID: 18595202
[TBL] [Abstract][Full Text] [Related]
18. Analysis of KL-6 and SP-D as disease markers in bird fancier's lung.
Janssen R; Grutters JC; Sato H; van Velzen-Blad H; Zanen P; Kohno N; Welsh KI; du Bois RM; van den Bosch JM
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Mar; 22(1):51-7. PubMed ID: 15881280
[TBL] [Abstract][Full Text] [Related]
19. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis.
Kobayashi I; Ono S; Kawamura N; Okano M; Miyazawa K; Shibuya H; Kobayashi K
J Pediatr; 2001 Feb; 138(2):274-6. PubMed ID: 11174630
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
